BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 24006435)

  • 1. HLA-DP polymorphisms affect the outcomes of chronic hepatitis B virus infections, possibly through interacting with viral mutations.
    Zhang Q; Yin J; Zhang Y; Deng Y; Ji X; Du Y; Pu R; Han Y; Zhao J; Han X; Zhang H; Cao G
    J Virol; 2013 Nov; 87(22):12176-86. PubMed ID: 24006435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population.
    Zhao Y; Chen K; Yang H; Zhang F; Ding L; Liu Y; Zhang L; Zhang Y; Wang H; Deng Y
    Virol J; 2023 Nov; 20(1):283. PubMed ID: 38037048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on association between HLA-DP gene polymorphism and susceptibility to hepatitis B virus infection in minority population in Guizhou province].
    Zhao X; He Y; Zhang T; Wang C; Zhang W; Yu W; Guan Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Mar; 37(3):389-93. PubMed ID: 27005543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development.
    Hu L; Zhai X; Liu J; Chu M; Pan S; Jiang J; Zhang Y; Wang H; Chen J; Shen H; Hu Z
    Hepatology; 2012 May; 55(5):1426-31. PubMed ID: 22105689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of functional nuclear factor-kappaB genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma.
    Zhang Q; Ji XW; Hou XM; Lu FM; Du Y; Yin JH; Sun XY; Deng Y; Zhao J; Han X; Yang GS; Zhang HW; Chen XM; Shen HB; Wang HY; Cao GW
    Ann Oncol; 2014 Dec; 25(12):2413-2419. PubMed ID: 25223483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus subgenotype C2- and B2-associated mutation patterns may be responsible for liver cirrhosis and hepatocellular carcinoma, respectively.
    Chen YM; Wu SH; Qiu CN; Yu DJ; Wang XJ
    Braz J Med Biol Res; 2013 Jul; 46(7):614-22. PubMed ID: 23903686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between chronic hepatitis B virus infection and HLA-DP gene polymorphisms in the Turkish population.
    Akgöllü E; Bilgin R; Akkız H; Ülger Y; Kaya BY; Karaoğullarından Ü; Arslan YK
    Virus Res; 2017 Mar; 232():6-12. PubMed ID: 28119119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between HLA-DP gene polymorphisms and clearance of chronic hepatitis B virus infections: case-control study and meta-analysis.
    Yan Z; Tan S; Dan Y; Sun X; Deng G; Wang Y
    Infect Genet Evol; 2012 Aug; 12(6):1222-8. PubMed ID: 22543033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
    Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
    Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between HLA variations and chronic hepatitis B virus infection in Saudi Arabian patients.
    Al-Qahtani AA; Al-Anazi MR; Abdo AA; Sanai FM; Al-Hamoudi W; Alswat KA; Al-Ashgar HI; Khalaf NZ; Eldali AM; Viswan NA; Al-Ahdal MN
    PLoS One; 2014; 9(1):e80445. PubMed ID: 24465366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of signal transducer and activator of transcription 3 polymorphisms with hepatitis B virus mutations in hepatocellular carcinoma.
    Xie J; Zhang Y; Zhang Q; Han Y; Yin J; Pu R; Shen Q; Lu W; Du Y; Zhao J; Han X; Zhang H; Cao G
    Hepatology; 2013 Jun; 57(6):2369-77. PubMed ID: 23386590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of HLA-DP/DQ, STAT4 and IL-28B variants with HBV viral clearance in Tibetans and Uygurs in China.
    Liao Y; Cai B; Li Y; Chen J; Ying B; Tao C; Zhao M; Ba Z; Zhang Z; Wang L
    Liver Int; 2015 Mar; 35(3):886-96. PubMed ID: 25041342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the rs3077 and rs9277535 polymorphisms in HLA-DP with hepatitis B virus infection and spontaneous clearance: a meta-analysis.
    Zhang XL; Ni XC; Jia JH; Dong JH; Yu FX; Ma N; Liu XH; Li M; Liu DW
    Scand J Gastroenterol; 2013 Jun; 48(6):736-44. PubMed ID: 23601003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the association of single nucleotide polymorphisms of HLA-DP and DQ genes with the outcome of chronic hepatitis B virus infection].
    Su M; Zeng Y; Chen J; Jiang L; Chen T; Liu C; Yang B; Ou Q
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Dec; 31(6):765-9. PubMed ID: 25449085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms of HLA-DP and isolated anti-HBc are important subsets of occult hepatitis B infection in Indonesian blood donors: a case-control study.
    Mardian Y; Yano Y; Wasityastuti W; Ratnasari N; Liang Y; Putri WA; Triyono T; Hayashi Y
    Virol J; 2017 Oct; 14(1):201. PubMed ID: 29061159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assessment of common genetic variations in HLA-DP with hepatitis B virus infection, clearance and hepatocellular carcinoma development.
    Yu L; Cheng YJ; Cheng ML; Yao YM; Zhang Q; Zhao XK; Liu HJ; Hu YX; Mu M; Wang B; Yang GZ; Zhu LL; Zhang S
    Sci Rep; 2015 Oct; 5():14933. PubMed ID: 26462556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of HLA-DPA1/DPB1 variants against Hepatitis B virus infection in an Indonesian population.
    Wasityastuti W; Yano Y; Ratnasari N; Triyono T; Triwikatmani C; Indrarti F; Heriyanto DS; Yamani LN; Liang Y; Utsumi T; Hayashi Y
    Infect Genet Evol; 2016 Jul; 41():177-184. PubMed ID: 27051043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of pri-miR-34b/c and pre-miR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma risk.
    Han Y; Pu R; Han X; Zhao J; Zhang Y; Zhang Q; Yin J; Xie J; Shen Q; Deng Y; Ding Y; Li W; Li J; Zhang H; Cao G
    PLoS One; 2013; 8(3):e58564. PubMed ID: 23516510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.
    Liu S; Zhang H; Gu C; Yin J; He Y; Xie J; Cao G
    J Natl Cancer Inst; 2009 Aug; 101(15):1066-82. PubMed ID: 19574418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.